Martin & Harris Labs reports robust results in FY21, PAT zooms 139% to Rs 177 Cr
New Delhi, January 15: Martin & Harris Laboratories, the pharmaceutical arm of Apeejay Group, has announced its results for the financial year ended on 31 March, 2021. In the financial year 2020-21, Martin & Harris Laboratories clocked a profit after tax (PAT) of Rs 177 crore, a rise of 138.96% against a net profit of…
Read More “Martin & Harris Labs reports robust results in FY21, PAT zooms 139% to Rs 177 Cr” »
